PubMed=1127734; DOI=10.1093/jnci/54.5.1037
Liao S.-K., Dent P.B., McCulloch P.B.
Characterization of human maligant melanoma cell lines. I. Morphology and growth characteristics in culture.
J. Natl. Cancer Inst. 54:1037-1044(1975)

PubMed=944091
McCulloch P.B., Dent P.B., Hayes P.R., Liao S.-K.
Common and individually specific chromosomal characteristics of cultured human melanoma.
Cancer Res. 36:398-404(1976)

DOI=10.1093/jnci/59.2.301
Quinn L.A., Woods L.K., Merrick S.B., Arabasz N.M., Moore G.E.
Cytogenetic analysis of twelve human malignant melanoma cell lines.
J. Natl. Cancer Inst. 59:301-307(1977)

PubMed=72600
Sharma B.
In vitro immunization against human tumor cells with tumor cell fractions.
Cancer Res. 37:4660-4668(1977)

PubMed=77569; DOI=10.1111/j.1399-0039.1978.tb01259.x
Espmark J.A., Ahlqvist-Roth L., Sarne L., Persson A.
Tissue typing of cells in culture. III. HLA antigens of established human cell lines. Attempts at typing by the mixed hemadsorption technique.
Tissue Antigens 11:279-286(1978)

PubMed=2423348; DOI=10.1016/0014-4827(86)90037-6
Trejdosiewicz L.K., Southgate J., Kemshead J.T., Hodges G.M.
Phenotypic analysis of cultured melanoma cells. Expression of cytokeratin-type intermediate filaments by the M5 human melanoma cell line.
Exp. Cell Res. 164:388-398(1986)

PubMed=1832891; DOI=10.1016/0277-5379(91)90277-K
Hansson J., Fichtinger-Schepman A.M.J., Edgren M.R., Ringborg U.
Comparative study of two human melanoma cell lines with different sensitivities to mustine and cisplatin.
Eur. J. Cancer 27:1039-1045(1991)

PubMed=8845476; DOI=10.1097/00001813-199510000-00005
Zhao R., Rabo Y.B., Egyhazi Brage S., Andersson A., Edgren M.R., Linder S., Hansson J.
Apoptosis and c-jun induction by cisplatin in a human melanoma cell line and a drug-resistant daughter cell line.
Anticancer Drugs 6:657-668(1995)

PubMed=17308088; DOI=10.1158/0008-5472.CAN-06-3311
Shields J.M., Thomas N.E., Cregger M., Berger A.J., Leslie M., Torrice C., Hao H.-L., Penland S., Arbiser J.L., Scott G.A., Zhou T., Bar-Eli M., Bear J.E., Der C.J., Kaufmann W.K., Rimm D.L., Sharpless N.E.
Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma.
Cancer Res. 67:1502-1512(2007)